Dr. Salvadore is an established industry executive physician and leader with more than 15 years of experience leading neurology-focused clinical development functions. He joined Alector in 2023 as ...

A fresh wave of layoffs jolted the Bay Area during March with several rounds of cutbacks that erased well over 600 jobs.

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology ...

Editor's note: The following deal was honored as part of the Business Times' 2024 Real Estate Deals of the Year. See all of ...

Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

As artificial intelligence continues to evolve, especially here in the Bay Area, one lab is working to use AI technology to find the next effective weight loss drug.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and ...

A bankruptcy filing Sunday by 23andMe, a genetic testing and biotechnology company, is shining light on what could happen to ...

After a rough patch, it seems the biotech industry may be staging a comeback. Several biotech firms have gone public this ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.